182 related articles for article (PubMed ID: 19234225)
1. Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease.
Zhu X; Gadgil AS; Givelber R; George MP; Stoner MW; Sciurba FC; Duncan SR
J Immunol; 2009 Mar; 182(5):3270-7. PubMed ID: 19234225
[TBL] [Abstract][Full Text] [Related]
2. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.
Barczyk A; Pierzchała W; Kon OM; Cosio B; Adcock IM; Barnes PJ
J Allergy Clin Immunol; 2006 Jun; 117(6):1484-92. PubMed ID: 16751017
[TBL] [Abstract][Full Text] [Related]
3. Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent.
Freeman CM; McCubbrey AL; Crudgington S; Nelson J; Martinez FJ; Han MK; Washko GR; Chensue SW; Arenberg DA; Meldrum CA; McCloskey L; Curtis JL
PLoS One; 2014; 9(5):e96421. PubMed ID: 24805101
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells.
Scrimini S; Pons J; Agustí A; Soriano JB; Cosio BG; Torrecilla JA; Núñez B; Córdova R; Iglesias A; Jahn A; Crespi C; Sauleda J
Respir Med; 2013 Dec; 107(12):1895-903. PubMed ID: 23993707
[TBL] [Abstract][Full Text] [Related]
5. Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease.
Hodge G; Mukaro V; Reynolds PN; Hodge S
Clin Exp Immunol; 2011 Oct; 166(1):94-102. PubMed ID: 21910726
[TBL] [Abstract][Full Text] [Related]
6. Increased CD8 T-cell granzyme B in COPD is suppressed by treatment with low-dose azithromycin.
Hodge S; Hodge G; Holmes M; Jersmann H; Reynolds PN
Respirology; 2015 Jan; 20(1):95-100. PubMed ID: 25308201
[TBL] [Abstract][Full Text] [Related]
7. Levels of CD4+ CD25+ T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms.
Sileikiene V; Laurinaviciene A; Lesciute-Krilaviciene D; Jurgauskiene L; Malickaite R; Laurinavicius A
Adv Respir Med; 2019; 87(3):159-166. PubMed ID: 31282557
[TBL] [Abstract][Full Text] [Related]
8. Distribution of CD4(+) and CD8(+) T cells in tumor islets and stroma from patients with non-small cell lung cancer in association with COPD and smoking.
Jackutė J; Žemaitis M; Pranys D; Šitkauskienė B; Miliauskas S; Bajoriūnas V; Sakalauskas R
Medicina (Kaunas); 2015 Nov; 51(5):263-71. PubMed ID: 26674143
[TBL] [Abstract][Full Text] [Related]
9. Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD.
Paats MS; Bergen IM; Hoogsteden HC; van der Eerden MM; Hendriks RW
Eur Respir J; 2012 Aug; 40(2):330-7. PubMed ID: 22183488
[TBL] [Abstract][Full Text] [Related]
10. Enhanced activation of circulating plasmacytoid dendritic cells in patients with Chronic Obstructive Pulmonary Disease and experimental smoking-induced emphysema.
Qiu SL; Kuang LJ; Tang QY; Duan MC; Bai J; He ZY; Zhang JQ; Li MH; Deng JM; Liu GN; Zhong XN
Clin Immunol; 2018 Oct; 195():107-118. PubMed ID: 29127016
[TBL] [Abstract][Full Text] [Related]
11. The Role of Human Leukocyte Antigen-DR in Regulatory T Cells in Patients with Virus-Induced Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Zhang L; Nie X; Luo Z; Wei B; Teng G
Med Sci Monit; 2021 Mar; 27():e928051. PubMed ID: 33651771
[TBL] [Abstract][Full Text] [Related]
12. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.
Domagała-Kulawik J; Hoser G; Dabrowska M; Chazan R
Respir Med; 2007 Jun; 101(6):1338-43. PubMed ID: 17118637
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
Freeman CM; Han MK; Martinez FJ; Murray S; Liu LX; Chensue SW; Polak TJ; Sonstein J; Todt JC; Ames TM; Arenberg DA; Meldrum CA; Getty C; McCloskey L; Curtis JL
J Immunol; 2010 Jun; 184(11):6504-13. PubMed ID: 20427767
[TBL] [Abstract][Full Text] [Related]
14. Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.
Popescu I; Drummond MB; Gama L; Coon T; Merlo CA; Wise RA; Clements JE; Kirk GD; McDyer JF
Am J Respir Crit Care Med; 2014 Oct; 190(7):744-55. PubMed ID: 25137293
[TBL] [Abstract][Full Text] [Related]
15. Tc2 response at the onset of COPD exacerbations.
Makris D; Lazarou S; Alexandrakis M; Kourelis TV; Tzanakis N; Kyriakou D; Gourgoulianis KI
Chest; 2008 Sep; 134(3):483-488. PubMed ID: 18490406
[TBL] [Abstract][Full Text] [Related]
16. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
17. The elastin peptide VGVAPG increases CD4
Lemaire F; Audonnet S; Perotin JM; Gaudry P; Dury S; Ancel J; Lebargy F; Antonicelli F; Deslée G; Le Naour R
Respir Res; 2021 Jan; 22(1):14. PubMed ID: 33435988
[TBL] [Abstract][Full Text] [Related]
18. Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
Geerdink JX; Simons SO; Pike R; Stauss HJ; Heijdra YF; Hurst JR
Respir Res; 2016 Oct; 17(1):140. PubMed ID: 27793198
[TBL] [Abstract][Full Text] [Related]
19. CD4-regulatory cells in COPD patients.
Smyth LJ; Starkey C; Vestbo J; Singh D
Chest; 2007 Jul; 132(1):156-63. PubMed ID: 17505034
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.
Barceló B; Pons J; Ferrer JM; Sauleda J; Fuster A; Agustí AG
Eur Respir J; 2008 Mar; 31(3):555-62. PubMed ID: 18057064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
